How we will partner with you
Open communication | Fully transparency | Agility and alignment
Developing and manufacturing biologics comes with its own unique set of difficulties and risks. Whether you are a small biotech or a large pharma, open communication between your organization and the CDMO partner is key to achieving success.
Collaborative and agile project management
approach
Our aim is to successfully deliver contracted deliverables within budget and time. To achieve this we commit to full transparency and alignment with you every step of the way. Our project management approach is built on a foundation of open communication and agility, with short and direct communication channels, allowing us to quickly adapt and respond to any obstacles that may arise.
Fully aligned throughout the whole project
- Short communication channels, by providing direct access to key HALIX project team members
- Project supervision by Sr. management of the customer & scientifically qualified Sr. management from HALIX
- Regular project team meetings that ensure progress, alignment, risk mitigation and proactive management of risks
- Specialized and interdisciplinary teams fully committed to the project’s success
Our team for your project
The HALIX project team consists of a project leader, QA/QP project lead, QC project lead, and business developer. The project leader is the main contact person and ensures the correct management of the project internally. The QA/QP lead is responsible for quality assurance, including material release and product release, while the QC lead is responsible for testing and reporting of the analysis associated with the project. Right from the start of the project, the business developer handles all contractual arrangements in close cooperation with you, and is involved in discussions about scope and conditions of the project.
Trusted by our partners around the world
“When we were looking for a CDMO partner to support the aseptic fill and finish activities, testing, and packaging of our lead compound with reliability and expertise, HALIX was the perfect fit. HALIX offered a full service to match our needs and provided us with the flexibility and collaboration that was necessary to deliver T-Guard® to clinical trials. HALIX’s attention to detail and close, transparent communication enabled us to meet our deadlines, successfully overcome challenges, and ensure the success of the project.”
Dr. Ypke van Ossterhout, Founder and CEO of Xenikos
“This collaboration with HALIX will ensure high quality, rapid and secure manufacture of clinical supplies for our current and future products. […] We developed a manufacturing process around the use of transient transfection to accelerate timelines and reduce costs, whilst delivering product of the highest quality. In HALIX we found the ideal partner; experience in transient transfection, modern facilities, strong leadership and a laser focus on delivery to bring NVG-111 from contract signature to vials of clinical drug in less than seven months.“
Kieran O’Donovan, COO & CTO at NovalGen
“We achieved on-time delivery of a completely novel vaccine while starting from a brand new empty facility and having to assemble all of the necessary equipment, processes, and qualifications for commercial production along the way. This success was only possible through our tight collaboration with AstraZeneca and our team’s internal work with military precision.“
Dennis Verbart, Senior Director Science and Technology at HALIX